comparemela.com

Latest Breaking News On - Australian natural therapeutics group - Page 2 : comparemela.com

Clever Leaves Holdings Inc (NASDAQ:CLVR) Q3 2023 Earnings Call Transcript

Clever Leaves Reports Second Quarter 2023 Results

- Total Revenue Increased 21% Year-Over-Year, Driven by 151% Year-Over-Year Growth in Cannabinoid Revenue - - Continued Expense Reductions Drive Improved Adjusted EBITDA Performance of ($2.1) Million - - July 2023 Sale of Portuguese Processing Assets Added $2.7 Million in Cash Following the End of Q2 - - Reaffirming Previously Announced 2023 Guidance - TOCANCIPÁ, Colombia, Aug. 14, 2023 (GLOBE NEWSWIRE) Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a gl

Clever Leaves Reports Second Quarter 2023 Results

Clever Leaves Reports Second Quarter 2023 Results

14.08.2023 - - Total Revenue Increased 21% Year-Over-Year, Driven by 151% Year-Over-Year Growth in Cannabinoid Revenue - - Continued Expense Reductions Drive Improved Adjusted EBITDA Performance of ($2.1) Million - - July 2023 Sale of Portuguese Processing .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.